Soros Fund Management’s Avidity Biosciences RNAM Stock Holding History

Soros Fund Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-840,976	Closed	-$60.7M	–	316
2025 Q4	$60.7M	Buy	+840,976	New	+$54.3M	0.7%	50

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Soros Fund Management's RNAM Position: Q1 2026 in Review

Soros Fund Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 840,976 shares — an estimated $60.7M sold.

Soros Fund Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $60.7M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Soros Fund Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Soros Fund Management sold 840,976 Avidity Biosciences shares in Q1 2026, an estimated $60.7M.
Soros Fund Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Soros Fund Management's Avidity Biosciences position peaked at $60.7M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Soros Fund Management's 13F filing for Q1 2026, filed 15 May 2026.